BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3142314)

  • 1. Mechanisms of thrombus formation and lysis.
    Stump DC; Mann KG
    Ann Emerg Med; 1988 Nov; 17(11):1138-47. PubMed ID: 3142314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostasis.
    Arnout J; Hoylaerts MF; Lijnen HR
    Handb Exp Pharmacol; 2006; (176 Pt 2):1-41. PubMed ID: 17001771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid selectively increases vascular endothelial tissue-type plasminogen activator production and reduces thrombus formation in the mouse.
    Larsson P; Alwis I; Niego B; Sashindranath M; Fogelstrand P; Wu MC; Glise L; Magnusson M; Daglas M; Bergh N; Jackson SP; Medcalf RL; Jern S
    J Thromb Haemost; 2016 Dec; 14(12):2496-2508. PubMed ID: 27706906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concepts of clot lysis.
    Francis CW; Marder VJ
    Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of hemostasis.
    Troy GC
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):5-20. PubMed ID: 3282384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis.
    Liu JN; Liu JX; Liu Bf BF; Sun Z; Zuo JL; Zhang Px PX; Zhang J; Chen Yh YH; Gurewich V
    Circ Res; 2002 Apr; 90(7):757-63. PubMed ID: 11964367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hemostatic system.
    Stassen JM; Arnout J; Deckmyn H
    Curr Med Chem; 2004 Sep; 11(17):2245-60. PubMed ID: 15379710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications.
    Napolitano F; Montuori N
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-specific thrombolytic agents.
    Collen D
    Klin Wochenschr; 1988; 66 Suppl 12():15-23. PubMed ID: 3126344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of fibrinolytic response - In vivo and in vitro studies.
    Kramkowski K; Leszczynska A; Buczko W
    Pharmacol Rep; 2015 Aug; 67(4):695-703. PubMed ID: 26321270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potentiating effect of platelet on plasminogen activation by tissue plasminogen activator.
    Deguchi K; Murashima S; Shirakawa S; Soria C; Soria J; Dunn F; Tobelem G
    Thromb Res; 1985 Dec; 40(6):853-61. PubMed ID: 3937289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of platelets and leukocytes in coagulation and fibrinolysis.
    Cucuianu M; Trif I
    Rev Roum Physiol (1990); 1992; 29(1-2):33-8. PubMed ID: 1472550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endothelium, thrombosis and fibrinolysis].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1997 Dec; 47(20):2227-31. PubMed ID: 9616910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.